To the Editor:
We read with great interest the report by Dr. Nagashima, et al, “Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor (TNF) agents in patients with rheumatoid arthritis”1. The article is of special importance in regard to accelerated atherosclerosis among patients with connective tissue disease, including rheumatoid arthritis (RA). In the study, the elevation of total and high molecular weight adiponectin was observed in patients with RA treated with both etanercept and infliximab.
To support the observations of those authors, we share our …
Address reprint requests to Dr. Kotyla. E-mail: pkotyla{at}slam.katowice.pl